Table 1 Demographic and clinical characteristics of 60 patients with JIA after 29 years of disease duration

Age, years

38.2 (30–45)

Female

42 (70)

Disease duration, years

29.4 (26–38)

Number of swollen joints

0 (0–12)

Number of tender joints

1 (0–16)

Number of joints with LROM

4 (0–56)

Number of active joints

0 (0–13)

PGA, VAS cm

1.5 (1–7.6)

Patient’s global well-being, VAS cm

2.0 (1–5.9)

HAQ

0.5 (0–1.6)

JADAS

4.8 (0.2–27.1)

JADI total

6 (0–73)

CRP, mg/l

2.0 (0–38)

ESR, mm/h

6.0 (2–60)

Vitamin A μmol/L

1.6 (0.9–2.4)

Vitamin D nmol/L

64 (26–100)

Patients in remission off medication

12 (20)

Patients with inactive disease on medication

8 (13)

Patients with persistently active disease

40 (67)

Patients on sDMARDs

19 (32)

Patients on biological immunosuppressants

21 (35)

Patients on glucocorticosteroids

6 (10)

Employed^a

46 (77)